Definitely sounding good mate. I think there's already probably...

Definitely sounding good mate.

I think there's already probably enough patient responses/data to push for a registrational trial.

If there's more responses in the latest expanded cohort than it should be a walk in.

The top 20 has only gotten stronger...Likely to be some accumulators in the pending month before the final readout is presented in conjunction with a market announcement.

Sounds like Dr Dan Shelly is ready to get this commercialised...Perhaps he knows what the final readout entails.

Getting good vibes for PTX-100.